Czech prime minister Petr Nečas expressed his support for the report presented by the Global Commission on Drug Policy

"I consider the report by the Global Commission on Drug Policy to be an important challenge by the heads of state and politicians who have signed it," claimed Petr Nečas, the prime minister of the Government of the Czech Republic. His statement was published by the Office of the Government as a part of the national drug coordinator`s press release.

Czech prime minister Petr Nečas commented last week on the report of the Global Commission on Drug Policy with a claim that drug policy must focus on interventions that are effective and economically efficient. "Above all, anti-drug policy should be based on effective and economically efficient preventive and treatment measures, not on the criminalisation of people who suffer from drug addiction but are not causing harm to others. The Czech anti-drug policy is basically going in the right direction, but we must not be afraid to promote more effective types of solutions and to be inspired by other states as well."

National drug coordinator Jindřich Vobořil stressed in his press release the importance of the involvement of high state and institutional officials in statements supporting an evidence-based drug policy, as was the case of the Global Commission on Drug Policy. "To call for a change in policy direction towards effective prevention and treatment is certainly not new in its content, but primarily by who signed this report at this time," addressing the fact that high officials tend not to call attention to drug policy issues that represent a very sensitive political agenda.

Although the report of the Global Commission on Drug Policy has been widely reported in the media as advocacy of the legalisation of drugs, this term is not mentioned in the report. The report rather called for the cessation of criminalising drug users and suggested that different drug control regimes should be subjected to experiments. The report also acknowledged the crucial importance of prevention and treatment interventions, including substitution treatment and the reduction of drug-related harm.